Abortion bans impact reproductive rights and broader healthcare access in the US

Following the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade, abortion access in the United States has become highly dependent on geography and socioeconomic status. As of August 2026, thirteen states—including Alabama, Texas, and Tennessee—have near-total abortion bans in effect.

Beyond direct reproductive care, these restrictions are creating significant disruptions across the wider medical landscape. Research indicates that abortion bans and medication restrictions are affecting treatments for cancer, chronic diseases, and autoimmune conditions. The legal environment has also impacted fertility services and the progress of clinical trials for various medical breakthroughs.

For patients, navigating these laws often requires significant financial and logistical resources, such as arranging travel, lodging, and childcare. Medical professionals also face challenges, as they must navigate complex legal frameworks that may impose penalties for providing care outside of narrow exceptions, potentially delaying medically necessary treatments.